Podcast—Nonclinical Considerations When Developing An Ophtalmic Drug by The Altascientist

Podcast—Nonclinical Considerations When Developing An Ophtalmic Drug

As an end-to-end CRO/CDMO, we have expert knowledge in all early stages of drug development, and we’re sharing that knowledge with you in The Altascientist: The Audiobook. 

Each issue is a deep dive into a specific area of early-phase drug development, providing insider tips, considerations, and case studies. 


Altasciences is a drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.

Science

As an end-to-end CRO/CDMO, we have expert knowledge in all early stages of drug development, and we’re sharing that knowledge with you in The Altascientist: The Audiobook. Each issue is a deep dive into a specific area of early-phase drug development, providing insider tips, considerations, and case studies. Altasciences is a drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.

Share Podcast—Nonclinical Considerations When Developing An Ophtalmic Drug

Sign up to save your podcasts

Podcast—Nonclinical Considerations When Developing An Ophtalmic Drug

Podcast—Nonclinical Considerations When Developing An Ophtalmic Drug